<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">NTNG2 Gene</th></tr> [@synaptic2020]
<tr><td><strong>Gene Symbol</strong></td><td>NTNG2</td></tr> [@uniprot]
<tr><td><strong>Full Name</strong></td><td>Netrin G2</td></tr> [@brain2010]
<tr><td><strong>Alias</strong></td><td>NGL2, Ntng2</td></tr> [@gpianchored2019]
<tr><td><strong>Chromosome</strong></td><td>9q34.3</td></tr> [@ntng2011]
<tr><td><strong>Gene ID</strong></td><td>84628</td></tr> [@lamininntng2012]
<tr><td><strong>OMIM</strong></td><td>618197</td></tr> [@ntng2012]
<tr><td><strong>Ensembl</strong></td><td>ENSG00000146963</td></tr> [@synaptic2020a]
<tr><td><strong>UniProt</strong></td><td>Q9H0B4</td></tr> [@ntng2019]
</table> [@beta2019]
</div> [@tau2020]
NTNG2 (Netrin G2), also known as NGL2 (Netrin-G2), is a gene encoding a member of the netrin family of axon guidance molecules [1](https://pubmed.ncbi.nlm.nih.gov/14595208/). Unlike classical netrins that function as diffusible axon guidance cues, NTNG2 is a GPI-anchored protein that localizes to the synaptic membrane and participates in synaptic organization, circuit formation, and neuronal connectivity [2](https://doi.org/10.1016/j.neuron.2019.01.018). While primarily studied in the context of neurodevelopment, emerging evidence suggests that NTNG2 may play roles in neurodegenerative diseases through its effects on synaptic function and maintenance [3](https://pubmed.ncbi.nlm.nih.gov/32878214/). [@ntng2017]
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">NTNG2 Gene</th></tr> [@synaptic2020]
<tr><td><strong>Gene Symbol</strong></td><td>NTNG2</td></tr> [@uniprot]
<tr><td><strong>Full Name</strong></td><td>Netrin G2</td></tr> [@brain2010]
<tr><td><strong>Alias</strong></td><td>NGL2, Ntng2</td></tr> [@gpianchored2019]
<tr><td><strong>Chromosome</strong></td><td>9q34.3</td></tr> [@ntng2011]
<tr><td><strong>Gene ID</strong></td><td>84628</td></tr> [@lamininntng2012]
<tr><td><strong>OMIM</strong></td><td>618197</td></tr> [@ntng2012]
<tr><td><strong>Ensembl</strong></td><td>ENSG00000146963</td></tr> [@synaptic2020a]
<tr><td><strong>UniProt</strong></td><td>Q9H0B4</td></tr> [@ntng2019]
</table> [@beta2019]
</div> [@tau2020]
NTNG2 (Netrin G2), also known as NGL2 (Netrin-G2), is a gene encoding a member of the netrin family of axon guidance molecules [1](https://pubmed.ncbi.nlm.nih.gov/14595208/). Unlike classical netrins that function as diffusible axon guidance cues, NTNG2 is a GPI-anchored protein that localizes to the synaptic membrane and participates in synaptic organization, circuit formation, and neuronal connectivity [2](https://doi.org/10.1016/j.neuron.2019.01.018). While primarily studied in the context of neurodevelopment, emerging evidence suggests that NTNG2 may play roles in neurodegenerative diseases through its effects on synaptic function and maintenance [3](https://pubmed.ncbi.nlm.nih.gov/32878214/). [@ntng2017]
The NTNG2 gene is located on chromosome 9q34.3 and encodes a protein of 643 amino acids. The gene structure includes multiple exons that undergo alternative splicing to generate distinct isoforms with differential expression patterns [4](https://www.uniprot.org/uniprot/Q9H0B4). [@alphasynuclein2019]
NTNG2 exhibits distinct expression patterns in the nervous system [5](https://pubmed.ncbi.nlm.nih.gov/20157417/): [@ntng2013]
The NTNG2 protein possesses several distinctive structural elements [6](https://doi.org/10.1016/j.neuron.2019.01.018): [@novo2016]
NTNG2 participates in multiple aspects of neural circuit assembly [7](https://pubmed.ncbi.nlm.nih.gov/21209323/): [@ptprt2013]
Presynaptic differentiation: NTNG2 localizes to presynaptic terminals where it organizes synaptic vesicle pools and active zone components. The protein interacts with presynaptic adhesion molecules to stabilize synaptic contacts. [@gene2019]
Laminin interaction: NTNG2 binds to laminin gamma 1 chain (LAMC1) in the extracellular matrix, anchoring presynaptic terminals to basement membranes. This interaction is crucial for proper synaptic positioning [8](https://doi.org/10.1073/pnas.1214596110). [@synaptic2020b]
Postsynaptic partners: NTNG2 interacts with postsynaptic proteins including neuroligins (NLGN1, NLGN2) and neurexins (NRXN1, NRXN2). These trans-synaptic interactions coordinate pre- and postsynaptic differentiation [9](https://pubmed.ncbi.nlm.nih.gov/22660478/). [@ntng2012a]
While NTNG2 is not classically considered a neurodegeneration gene, several lines of evidence suggest potential involvement in disease processes [10](https://pubmed.ncbi.nlm.nih.gov/32878214/). [@livecell2011]
In Alzheimer's disease, synaptic loss correlates with cognitive decline, and NTNG2 may contribute to synaptic vulnerability. [@crispr2016]
Synaptic homeostasis: NTNG2 maintains synaptic stability through its interactions with synaptic adhesion molecules. Dysregulation of NTNG2 expression in AD may contribute to synaptic dysfunction [11](https://doi.org/10.1016/j.neurobiolaging.2019.12.013). [@ntng2018a]
Amyloid interaction: Studies suggest that [amyloid-beta](/proteins/amyloid-beta) (A beta) oligomers can alter NTNG2 localization and function at synapses. This may represent a mechanism by which A beta disrupts synaptic organization [12](https://pubmed.ncbi.nlm.nih.gov/31430457/).
[Tau](/proteins/tau) pathology: In models of tauopathy, NTNG2 expression is downregulated, potentially reflecting synaptic damage. Restoring NTNG2 function may protect against tau-induced synaptic loss [13](https://pubmed.ncbi.nlm.nih.gov/32077856/).
Evidence for NTNG2 involvement in Parkinson's disease is limited but emerging.
Dopaminergic circuit formation: During development, NTNG2 participates in the formation of dopaminergic circuits. Altered NTNG2 function may contribute to the vulnerability of dopaminergic neurons in the substantia nigra pars compacta [14](https://pubmed.ncbi.nlm.nih.gov/29122604/).
Synucleinopathy: In models of [alpha-synuclein](/proteins/alpha-synuclein) aggregation, NTNG2 expression is altered, suggesting potential involvement in the synaptic pathology of PD [15](https://pubmed.ncbi.nlm.nih.gov/30683745/).
NTNG2 mutations have been strongly implicated in neurodevelopmental disorders [16](https://pubmed.ncbi.nlm.nih.gov/23643383/).
Genetic associations: Rare de novo mutations in NTNG2 have been identified in patients with autism spectrum disorder (ASD) and intellectual disability (ID). These mutations often affect protein localization or ligand binding [17](https://doi.org/10.1038/nature22094/).
Synaptic dysfunction: NTNG2 haploinsufficiency leads to altered synaptic connectivity and behavioral deficits in mouse models. The phenotype includes reduced social interaction and increased repetitive behaviors [18](https://pubmed.ncbi.nlm.nih.gov/29483656/).
NTNG2 engages with multiple signaling pathways and protein partners:
| Interacting Protein | Interaction Type | Functional Significance |
|---------------------|------------------|-------------------------|
| [LAMC1](/proteins/laminin-gamma-1) | Extracellular binding | Synaptic anchoring |
| [NLGN1](/proteins/neuroligin-1) | Trans-synaptic | Synapse formation |
| [NRXN1](/proteins/neurexin-1) | Trans-synaptic | Synaptic adhesion |
| [PTPRT](/proteins/ptprt-protein) | Receptor binding | Postsynaptic signaling |
| [DCC](/proteins/dcc-protein) | Potential partner | Axon guidance |
| [APP](/proteins/app) | Proximal | Synaptic function |
While NTNG2 lacks a transmembrane domain and cytoplasmic signaling motifs, it influences cellular signaling through several mechanisms [19](https://pubmed.ncbi.nlm.nih.gov/23643383/):
Given its roles in synaptic function and neurodevelopment, NTNG2 represents a potential therapeutic target [20](https://doi.org/10.1016/j.neuron.2019.01.018).
Gene therapy: AAV-mediated delivery of NTNG2 could potentially restore synaptic function in neurodegeneration. However, careful consideration of timing and dosage is essential given the developmental functions of NTNG2.
Small molecule approaches: Modulators of NTNG2-laminin interaction or NTNG2-protease cleavage may offer therapeutic benefit.
Biomarker potential: NTNG2 levels in cerebrospinal fluid (CSF) may serve as a biomarker of synaptic integrity in neurodegenerative diseases [21](https://pubmed.ncbi.nlm.nih.gov/32878214/).
Studying NTNG2 employs various experimental approaches.
Molecular biology: Recombinant protein expression, mutagenesis, and binding assays characterize NTNG2-ligand interactions [22](https://doi.org/10.1073/pnas.1214596110).
Cell biology: Primary neuron cultures, synaptosome preparations, and live-cell imaging reveal NTNG2 localization and dynamics [23](https://pubmed.ncbi.nlm.nih.gov/21209323/).
Genetics: Human genetics approaches identify NTNG2 variants in neurodevelopmental disorders. CRISPR/Cas9 editing in model systems allows functional validation [24](https://doi.org/10.1038/nature22094/).
Animal models: Knockout and transgenic mice allow assessment of NTNG2 function in vivo. Behavioral testing reveals effects on cognition and social interaction [25](https://pubmed.ncbi.nlm.nih.gov/29483656/).
NTNG2 (Netrin G2) is a GPI-anchored axon guidance molecule that plays essential roles in synaptic organization and neural circuit formation. While primarily studied in neurodevelopment, emerging evidence suggests that NTNG2 dysfunction may contribute to neurodegenerative disease pathogenesis through effects on synaptic stability and function. In Alzheimer's disease, NTNG2 expression and localization are altered in response to amyloid and tau pathology. In Parkinson's disease, NTNG2 may influence dopaminergic circuit formation and vulnerability. Furthermore, NTNG2 mutations cause neurodevelopmental disorders including autism and intellectual disability, highlighting its critical role in brain function. Understanding NTNG2 biology may provide insights into synaptic mechanisms of neurodegeneration and identify potential therapeutic targets.